Childhood nephrotic syndrome

References

• Barnett HL et al: The nephrotic syndrome in children. In Levine S (Editor): Advances in Pediatrics. Chicago, Year Book Medical Publishers Inc. 1952, vol 5, p 53
   Google Scholar
• Heymann W: Pathogenesis of the nephrotic syndrome: Considerations based on clinical and experimental studies. J Pediatr 58: 609–619,1961
   PubMed Web of Science ®Google Scholar
• Churg J et al: Pathology of the nephrotic syndrome in children: A report for the International Study of Kidney Disease in Children. Lancet 1: 1299–1302, 1970
   Web of Science ®Google Scholar
• White RH et al: Clinicopathological study of nephrotic syndrome in childhood. Lancet 1: 1353–1359, 1970
   PubMed Web of Science ®Google Scholar
• Wilson SG, Heymann W: Acute glomerulonephritis with the nephrotic syndrome. Pediatrics 23: 874–878, 1959
   PubMed Web of Science ®Google Scholar
• Habib R et al: Idiopathic membrano-proliferative glomerulonephritis in children. Report of 105 cases. Clin Nephrol 1: 194–214, 1973
   Google Scholar
• Rothenberg MB, Heymann W: The incidence of the nephrotic syndrome in children. Pediatrics 19: 446–452, 1957
   PubMed Web of Science ®Google Scholar
• Arneil GC: The nephrotic syndrome. Pediatr Clin North Am 18: 547–559, 1971
   PubMed Web of Science ®Google Scholar
• Schlesinger ER et al: The nephrotic syndrome: Its incidence and implications for the community. Am J Dis Child 116: 623–632, 1968
   PubMedGoogle Scholar
• Makker SP, Heymann W: The idiopathic nephrotic syndrome of childhood: A clinical reevaluation of 148 cases. Am J Dis Child 127: 830–837, 1974
   PubMedGoogle Scholar
• Cameron JS, Blandford G: The simple assessment of selectivity in heavy proteinuria. Lancet 2: 242–247, 1966
   PubMed Web of Science ®Google Scholar
• McAdams AJ et al: Mesangiocapillary glomerulonephritis: Changes in glomerular morphology with long-term alternate-day prednisone therapy. J Pediatr 86: 23–31, 1975
   PubMed Web of Science ®Google Scholar
• Cole BR et al: “Pulse” methylprednisolone therapy in the treatment of severe glomerulonephritis. J Pediatr 88: 307–314, 1976
   PubMed Web of Science ®Google Scholar
• Cameron JS et al: Membranoproliferative glomerulonephritis and persistent hypocomplementaemia. Br Med J 4: 7–14, 1970
   PubMed Web of Science ®Google Scholar
• Grupe WE: Nephropathies. In Schaffer A J, Avery ME: Diseases of the Newborn. Ed 4. Philadelphia, WB Saunders Co, 1977, chap 51, p 471
   Google Scholar
• Shahin B et al: Congenital nephrotic syndrome associated with congenital toxoplasmosis. J Pediatr 85: 366–370, 1974
   PubMed Web of Science ®Google Scholar
• Habib R, Bois E: Héterogénéité des syndromes néphrotiques à debut précoce du nourrisson (syndrome néphrotique “infantile”): Etude anatomo-clinique et génétique de 37 observations. Helv Paediatr Acta 28: 91–107, 1973
   PubMedGoogle Scholar
• Ingelfinger JR: Nephrotic syndrome in the second decade of life. (Abstr) Pediatr Res 11: 372, 1977
   Web of Science ®Google Scholar
• Abramowicz M et al: Controlled trial of azathioprine in children with nephrotic syndrome: A report for the International Study of Kidney Disease in Children. Lancet 1: 959–961, 1970
   PubMed Web of Science ®Google Scholar
• Ameil GC, Lam CN: Long-term assessment of steroid therapy in childhood nephrosis. Lancet 2: 819–821,1966
   PubMed Web of Science ®Google Scholar
• Cornfeld D, Schwartz MW: Nephrosis: A long-term study of children treated with corticosteroids. J Pediatr 68: 507–515, 1966
   Web of Science ®Google Scholar
• Siegel NJ et al: Long-term follow-up of children with steroid-responsive nephrotic syndrome. J Pediatr 81: 251–258, 1972
   PubMed Web of Science ®Google Scholar
• Schwartz MW et al: A 16-year follow-up study of 163 children with nephrotic syndrome. Pediatrics 54: 547–552, 1974
   PubMed Web of Science ®Google Scholar
• White RH: Cytotoxic drug therapy in steroid-resistant glomerulonephritis. Proc R Soc Med 60: 1164–1168, 1967
   PubMedGoogle Scholar
• McCrory WW et al: Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome. J Pediatr 82: 614–618, 1973
   PubMed Web of Science ®Google Scholar
• Soyka LF, Saxena KM: Alternate-day steroid therapy for nephrotic children. JAMA 192: 225–230, 1965
   PubMed Web of Science ®Google Scholar
• Lange K et al: Prolonged intermittent steroid therapy for nephrosis in children and adults. JAMA 168: 377–381, 1958
   PubMed Web of Science ®Google Scholar
• Brodehl J, Krohn HP: Steroid trial in frequently relapsing nephrotic syndrome in children. In Kluthe R et al (Editors): Glomerulonephritis. Stuttgart, George Thieme Publishers, 1976, pp 210–215
   Google Scholar
• Rance CP et al: Management of the nephrotic syndrome in children. Pediatr Clin North Am 23: 735–750, 1976
   PubMed Web of Science ®Google Scholar
• Barratt TM, Soothill JF: Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood. Lancet 2: 479–482, 1970
   PubMed Web of Science ®Google Scholar
• Chiu J et al: A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood. J Pediatr 82: 607–613, 1973
   PubMed Web of Science ®Google Scholar
• Prospective, controlled trial of cyclophosphamide therapy in children with the nephrotic syndrome. Report of the International Study of Kidney Disease in Children. Lancet 2: 423–427, 1974
   Google Scholar
• Grupe WE: Chlorambucil in steroid-dependent nephrotic syndrome. J Pediatr 82: 598–606, 1973
   PubMed Web of Science ®Google Scholar
• Grupe WE et al: Chlorambucil treatment of frequently relapsing nephrotic syndrome. N Engl J Med 295: 746–749, 1976
   PubMed Web of Science ®Google Scholar
• Penso J et al: Testicular function in prepubertal and pubertal male patients treated with cyclophosphamide for nephrotic syndrome. J Pediatr 84: 831–836, 1974
   PubMed Web of Science ®Google Scholar
• Etteldorf JN et al: Gonadal function, testicular histology, and meiosis following cyclophosphamide therapy in patients with nephrotic syndrome. J Pediatr 88: 206–212, 1976
   PubMed Web of Science ®Google Scholar
• Williams SA et al: Long-term evaluation of chlorambucil, including effects of dose, in idiopathic nephrotic syndrome of childhood. Pediatr Res 11: 560, 1977
   Web of Science ®Google Scholar
• Williams SA et al: Seizures: A significant side effect of chlorambucil therapy in children. J Pediatr 93: 516–518, 1978
   PubMed Web of Science ®Google Scholar
• Richter P et al: Effect of chlorambucil on spermatogenesis in the human with malignant lymphoma. Cancer 25: 1026–1030, 1970
   PubMed Web of Science ®Google Scholar
• Westberg NG, Swolin B: Acute myeloid leukemia appearing in two patients after prolonged continuous chlorambucil treatment for Wegener's granulomatosis. Acta Med Scand 199: 373–377, 1976
   PubMedGoogle Scholar